International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes

European Journal of Heart Failure

Volumn 12, Issue 11, 2010, Pages 1253-1260

  Collins, Sean P ^a   Pang, Peter S ^b   Lindsell, Christopher J ^a   Kyriacou, Demetrios N ^b   Storrow, Alan B ^c   Hollander, Judd E ^d   Douglas Kirk, J ^e   Miller, Chadwick D ^f   Nowak, Richard ^g   Frank Peacock, W ^h   Tavares, Miguel ⁱ   Mebazaa, Alexandre ^j   Gheorghiade, Mihai ^k  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g HENRY FORD HOSPITAL   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^j HÔPITAL LARIBOISIÈRE   (France)

^k NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Emergency; Geographical differences; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; NATRIURETIC FACTOR; NESIRITIDE; NITROPRUSSIDE SODIUM; TORASEMIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; DIURETIC THERAPY; DYSPNEA; EASTERN EUROPE; EMERGENCY MEDICINE; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HEART EJECTION FRACTION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; UNITED STATES; WESTERN EUROPE;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NITROGLYCERIN; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PHYSICIAN'S PRACTICE PATTERNS; RADIOGRAPHY, THORACIC;

EID: 77958606969     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq133     Document Type: Article

References (23)

1. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am CollCardiol 2008;52:1640-1648.
2. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-2736.
3. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-777.
4. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209-216.
5. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programme\-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463. (Pubitemid 36286187)
6. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, Van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. J Am Med Assoc 2007;298:2009-2019.
7. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. J Am Med Assoc 2007;297: 1332-1343.
8. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. J Am Med Assoc 2002;287: 1531-1540.
9. Pang PS, Tavares M, Collins SP, Cleland JG, Hollander J, Nieminen M, Miller C, Courtney DM, Kirk JD, Masip J, Parkhomenko A, Macarie C, Peacock WF, Spinar J, Nowak R, Raev D, Storrow AB, Spisak V, Hamdy A, Mebazaa A, Gheorghiade M. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther 2008;15:299-303.
10. Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Courtney DM, Hasa J, Spinar J, Masip J, Peacock WF, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 2010;31:832-841.
11. Pitt B, Zannad F, Gheorghiade M, Martinez F, Love TE, Daniel C, Ahmed A. Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial. Int J Cardiol 2009. Epub ahead of print.
12. Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J 2009;158:437-443
13. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hos-pitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-1028.
14. Nicol ED, Fittall B, Roughton M, Cleland JG, Dargie H, Cowie MR. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart (British Cardiac Society) 2008;94:172-177.
15. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail 12:499-507.
16. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008;10:165-169.
17. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998;351:389-393.
18. Cotter G, Felker GM, Adams KF, Milo-Cotter O, O'Connor CM. The pathophy-siology of acute heart failure-is it all about fluid accumulation? Am Heart J 2008; 155:9-18.
19. Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, Dunne R, Zalenski R. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med 2007;50:144-152.
20. De Luca L, Mebazaa A, Filippatos G, Parissis JT, Bohm M, Voors AA, Nieminen M, Zannad F, Rhodes A, El-Banayosy A, Dickstein K, Gheorghiade M. Overview of emerging pharmacologic agents for acute heart failure syndromes. Eur J Heart Fail 2008;10:201-213.
21. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008;29:816-824.
22. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, Committee ASA Investiga-torsTemporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-1028.
23. Collins SP, Peacock WF, Lindsell CJ, Clopton P, Diercks DB, Hiestand B, Hogan C, Kontos MC, Mueller C, Nowak R, Chen WJ, Huang CH, Abraham WT, Amsterdam E, Breidthardt T, Daniels L, Hasan A, Hudson M, McCord J, Naz T, Wagoner LE, Maisel A. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med 2009;53:748-757.